Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Zogenix Inc. : Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

05/03/2013 | 08:40am US/Eastern
Recommend:
0
Conference Call Scheduled for May 9, 2013 at 4:30 pm ET

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial (866) 318-8616 (U.S.) or (617) 399-5135 (International); participant passcode: 65838569.

The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.

A replay of the conference call will be available beginning May 9, 2013 at 6:30 p.m. ET (3:30 p.m. PT) until May 16, 2013, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 23471504. A replay of the webcast will also be accessible on the Investor Relations website for one month, through June 9, 2013.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, Zohydro™ ER (hydrocodone bitartrate), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER. Zogenix's second investigational product candidate, Relday™, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia; an investigational new drug application was submitted to the FDA in May 2012. For additional information, please visit www.zogenix.com.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Caitlin Cox | The Ruth Group
         646.536.7033 | ccox@theruthgroup.com
Zogenix
distributed by
Recommend :
0
React to this article
Latest news
Date Title
3m ago Euro Ready for a Short-term Breakout, Trend Revival When Liquidity Returns
5m ago PRESTIGE : Holistic Company Report by The Stock Reseach Center
9m ago MARRIOTT VACATIONS WORLDWIDE : 'Next Gen' & Innovation Focus Of Vacation Ownership Industry Annual Convention
17m agoDJDLF : Behind a Real-Estate Empire, Ties to India's -2-
17m agoDJDLF : Behind a Real-Estate Empire, Ties to India's Gandhi Dynasty
20m ago COMPANHIA DE SANEAMENTO BASICO SABESP : SABESP : Announces Tariff Revision
20m ago ZTE : Provides Technical Support as Air China Launches its First Ground-Air Broadband Test
21m ago NCKU Professor’s Research on Bike-Share System Published in ‘Operations Research’
27m agoDJGains in China Average New Home Prices Slow in March
32m ago APICS : and APICS : Foundation Honor Rockwell Automation for Supply Chain Management Excellence
Latest news
Advertisement
Hot News 
INDEPENDENT BANK : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Directors or Principal Officers (form 8-K)
HAYNES PUBLISHING : Third Quarter Hit By Us Inventory Returns, Weak UK
SPACEANDPEOPLE : Shares Slide As It Lowers 2014 Forecast
BLUR : Shares In Blur Group Plummet Due To Delayed Revenue Recognition
LDK SOLAR : Provides Additional Information on its Request for Review of NYSE Regulation's Decision to Suspend Trading and Commence Delisting Procedures
Most Read News
4h ago WALT DISNEY : Disney sees operating income growth at cable networks
4h ago LULULEMON ATHLETICA : CEO looks beyond yoga wear for growth
4h ago BLACKSTONE : Retailer Michaels Stores confirms payment card data breach
5h ago APPLE : Pixel Film Studios, Apple FCPX Effects Developer Announced the Release of ProSilent, Professional Silent Film Effects.
5h ago PNC FINANCIAL SERVICES : The Mission Continues, PNC Bank to Host Community Service Project to Refurbish Grace Hill Early Childhood Development Center
Most recommended articles
15h ago U.S. shares seen opening lower as tech giants stumble
11h ago Financials bolster FTSE after reassuring U.S. earnings
14h ago BLACKSTONE : earnings rise 30 percent, boosted by private equity gains
04/10DJCarrefour Sales Grow at Fastest Pace in Two Years
2m ago Euro Ready for a Short-term Breakout, Trend Revival When Liquidity Returns
Dynamic quotes  
ON
| OFF